Two Sigma Securities »

Candel Therapeutics shares owned by Two Sigma Securities

Quarter-by-quarter ownership of Candel Therapeutics (CADL) shares owned by Two Sigma Securities from 13F filings

Historical chart of Two Sigma Securities investment in Candel Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Candel Therapeutics held by Two Sigma Securities consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Candel Therapeutics by Two Sigma Securities

Quarter filed Position value Share count Share price at filing
2023-12-31 $24k 17k 1.47

More positions owned by Two Sigma Securities

NVIDIA Corporation Call Option (NVDA)
Meta Platforms Cl A Call Option (META)
Microsoft Corporation (MSFT)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Amazon (AMZN)
Tesla Motors Call Option (TSLA)
Apple Call Option (AAPL)
Chevron Corporation (CVX)
Advanced Micro Devices Call Option (AMD)
Netflix Call Option (NFLX)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Broadcom (AVGO)
Super Micro Computer Call Option (SMCI)
Eli Lilly & Co. Call Option (LLY)
Lockheed Martin Corporation Call Option (LMT)

View all positions for Two Sigma Securities

Top funds holding Candel Therapeutics

Northpond Ventures
Sands Capital Ventures
Vanguard Group
Geode Capital Management
Bridgeway Capital Management
Baystate Wealth Management
BlackRock
Mariner Wealth Advisors
Resources Investment Advisors
Northern Trust
Commonwealth Equity Services
Two Sigma Investments
Tower Research Capital
Jpmorgan Chase & Co
Wells Fargo & Company

View all funds holding Candel Therapeutics